Home > Press > New York Biotechnology Association Names Nathan Tinker as Its Executive Director
The New York Biotechnology Association (NYBA, www.nyba.org), a not-for-profit trade association dedicated to the development and growth of New York State-based biotechnology related industries, announced today that Nathan Tinker has been named Executive Director of the association. Dr. Tinker brings extensive leadership experience and abilities to the post as well as a history of achievements providing strategic business direction to an array of clients and commercial organizations. This appointment was effective as of March 5, 2007.
New York Biotechnology Association Names Nathan Tinker as Its Executive Director
New York, NY | Posted on March 13th, 2007
"The NYBA Board of Directors is very pleased to have Nathan join as Executive Director of the organization," stated Robert L. Van Nostrand, Chairman of the NYBA Board and Senior Vice President and Chief Compliance Officer, OSI Pharmaceuticals, Inc. "We were impressed with his accomplishments and professional experience, and we believe that his vision, leadership qualities and determination will be critical assets in support of our organization's growth and overall position within an evolving biotechnology marketplace in New York State."
"I am honored to be selected as the new Executive Director of NYBA," said Nathan Tinker, Ph.D. "I look forward to working with the experienced and knowledgeable NYBA Board as well as all of the membership to further strengthen the competitiveness of New York State as an industry leader in biomedical research, education and product development."
Dr. Tinker has an extensive background in high technology public policy, communications, and industry relations. He formerly served as Founder and Executive Vice President of the NanoBusiness Alliance, the trade association of the nanotechnology community, as well as Executive Director of the Cancer Vaccine Consortium at the Sabin Vaccine Institute. Most recently, Dr. Tinker served as Director of Antenna Group's East Coast office leading communication initiatives for the company's biotechnology and high tech clients. Dr. Tinker holds a Ph.D. from Fordham University and an M.A. from Georgetown University and is a graduate of Gonzaga University with a degree in English.
About New York Biotechnology Association
NYBA is the leading advocate for advancing the success of the biotechnology industry in New York State and is its main representative to policy makers, the media and the communities in which we work. Our mission is to support the development and growth of New York’s biotechnology industry, and serve our members and the biotechnology community by providing a network for information exchange, shared services and collective action. NYBA’s membership comprises over 250 bioscience companies, world-class research institutions and related professional services. Under the banner of The Cures Start Here®, our goal is to amplify the success New York has had and continues to have in discovering major medical advances and growing a vibrant biotech industry. For more information on NYBA programs and initiatives, visit our website at http://www.nyba.org .
For more information, please click here
The New York Biotechnology Association
Nathan Tinker, Executive Director, 631-444-8895
Paul Kidwell, 617-296-3854
Copyright © Business Wire
If you have a comment, please Contact
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
The thunder god vine, assisted by nanotechnology, could shake up future cancer treatment: Targeted therapy for hepatocellular carcinoma using nanotechnology August 27th, 2014
Creation of a Highly Efficient Technique to Develop Low-Friction Materials Which Are Drawing Attention in Association with Energy Issues August 26th, 2014
Competition for Graphene: Berkeley Lab Researchers Demonstrate Ultrafast Charge Transfer in New Family of 2D Semiconductors August 26th, 2014
Symphony of nanoplasmonic and optical resonators leads to magnificent laser-like light emission August 26th, 2014
Nanometrics CFO to Resign for New Job Opportunity August 8th, 2014
California Nanotechnologies Appoints Dr. Enrique Lavernia to the Board August 6th, 2014
ACS Biomaterials Science & Engineering™: Brand-new journal names editor July 29th, 2014
Organometallics welcomes new editor-in-chief: Paul Chirik, Ph.D. July 22nd, 2014